BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 16357190)

  • 1. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
    Cheng I; Plummer SJ; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
    Lindmark F; Zheng SL; Wiklund F; Bensen J; Bälter KA; Chang B; Hedelin M; Clark J; Stattin P; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
    J Natl Cancer Inst; 2004 Aug; 96(16):1248-54. PubMed ID: 15316060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study.
    Smit LA; Bongers SI; Ruven HJ; Rijkers GT; Wouters IM; Heederik D; Omland Ø; Sigsgaard T
    Clin Exp Allergy; 2007 Nov; 37(11):1602-8. PubMed ID: 17877764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer.
    Srivastava K; Srivastava A; Kumar A; Mittal B
    Liver Int; 2010 Aug; 30(7):1067-72. PubMed ID: 20492496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
    Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
    Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer.
    Garza-Gonzalez E; Bosques-Padilla FJ; Mendoza-Ibarra SI; Flores-Gutierrez JP; Maldonado-Garza HJ; Perez-Perez GI
    BMC Cancer; 2007 Apr; 7():70. PubMed ID: 17462092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens.
    Schulz S; Zissler N; Altermann W; Klapproth J; Zimmermann U; Gläser C; Schaller HG; Reichert S
    Int J Immunogenet; 2008 Dec; 35(6):457-64. PubMed ID: 19046305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
    Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
    Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
    Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study.
    Snelgrove T; Lim S; Greenwood C; Peddle L; Hamilton S; Inman R; Rahman P
    J Rheumatol; 2007 Feb; 34(2):368-70. PubMed ID: 17143969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.
    Zheng SL; Augustsson-Bälter K; Chang B; Hedelin M; Li L; Adami HO; Bensen J; Li G; Johnasson JE; Turner AR; Adams TS; Meyers DA; Isaacs WB; Xu J; Grönberg H
    Cancer Res; 2004 Apr; 64(8):2918-22. PubMed ID: 15087412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma.
    Shibuya E; Meguro A; Ota M; Kashiwagi K; Mabuchi F; Iijima H; Kawase K; Yamamoto T; Nakamura M; Negi A; Sagara T; Nishida T; Inatani M; Tanihara H; Aihara M; Araie M; Fukuchi T; Abe H; Higashide T; Sugiyama K; Kanamoto T; Kiuchi Y; Iwase A; Ohno S; Inoko H; Mizuki N
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4453-7. PubMed ID: 18586872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.